<DOC>
	<DOCNO>NCT02390102</DOCNO>
	<brief_summary>The objective study evaluate efficacy Erythropoietin ( EPO ) ( + iron ) reduce rate red blood cell transfusion requirement patient aortic stenosis undergo transcatheter aortic valve replacement .</brief_summary>
	<brief_title>Erythropoietin + Iron Therapy Anemic Patients Undergoing Aortic Valve Replacement</brief_title>
	<detailed_description>STUDY DESIGN Prospective randomize double blind study include patient diagnose severe symptomatic aortic stenosis anemia undergo aortic valve replacement . The patient identify cardiac surgery / aortic stenosis outpatient clinic hospitalization department Institut Universitaire de Cardiologie et de Pneumologie de Quebec . SAMPLE SIZE 100 patient ( 50 patient per group ) .</detailed_description>
	<mesh_term>Constriction , Pathologic</mesh_term>
	<mesh_term>Aortic Valve Stenosis</mesh_term>
	<mesh_term>Epoetin Alfa</mesh_term>
	<criteria>1 . Patients ≥60year old 2 . Symptomatic aortic stenosis clinical indication transcatheter aortic valve replacement , regardless simultaneous percutaneous coronary intervention 3 . Anemia define accord World Health Organization ( WHO ) definition 69 : 1 . Men : Hemoglobin &lt; 130 g/L 2 . Women : &lt; 120 g/L 1 . Contraindication transcatheter aortic valve replacement . 2 . Erythropoietin treatment within last 30 day Aortic Valve Replacement 3 . Known anemia due aplasia , hemoglobinopathy active bleeding require blood transfusion within last 30 day Aortic Valve Replacement 4 . Ferritin &gt; 800 µg/L 5 . Uncontrolled hypertension ( Blood pressure &gt; 175/95 ) 6 . Platelet count &gt; 450,000/L 7 . Recent myocardial infarction require percutaneous coronary intervention disable stroke ( within last 30 day ) 8 . Dialysis patient 9 . Hemodynamic instability define need hemodynamic support inotropic drug , intraortic balloon pump counterpulsation leave ventricular assist device index procedure 10 . Active cancer high risk thromboembolic event 11 . Known allergy hypersensitivity intravenous iron Erythropoietin therapy 12 . No write consent</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Anemia</keyword>
	<keyword>Severe aortic stenosis</keyword>
	<keyword>Red blood cell transfusion</keyword>
	<keyword>Erythropoietin</keyword>
</DOC>